Literature DB >> 18056244

Lateralized caudate metabolic abnormalities in adolescent major depressive disorder: a proton MR spectroscopy study.

Vilma Gabbay1, David A Hess, Songtao Liu, James S Babb, Rachel G Klein, Oded Gonen.   

Abstract

OBJECTIVE: Proton magnetic resonance spectroscopy ((1)H-MRS) has been increasingly used to examine striatal neurochemistry in adult major depressive disorder. This study extends the use of this modality to pediatric major depression to test the hypothesis that adolescents with major depression have elevated concentrations of striatal choline and creatine and lower concentrations of N-acetylaspartate.
METHOD: Fourteen adolescents (ages 12-19 years, eight female) who had major depressive disorder for at least 8 weeks and a severity score of 40 or higher on the Children's Depression Rating Scale-Revised and 10 healthy comparison adolescents (six female) group-matched for gender, age, and handedness were enrolled. All underwent three-dimensional 3-T (1)H-MRS at high spatial resolution (0.75-cm(3) voxels). Relative levels of choline, creatine, and N-acetylaspartate in the left and right caudate, putamen, and thalamus were scaled into concentrations using phantom replacement, and levels were compared for the two cohorts.
RESULTS: Relative to comparison subjects, adolescents with major depressive disorder had significantly elevated concentrations of choline (2.11 mM versus 1.56 mM) and creatine (6.65 mM versus 5.26 mM) in the left caudate. No other neurochemical differences were observed between the groups.
CONCLUSIONS: These findings most likely reflect accelerated membrane turnover and impaired metabolism in the left caudate. The results are consistent with prior imaging reports of focal and lateralized abnormalities in the caudate in adult major depression.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18056244      PMCID: PMC2774821          DOI: 10.1176/appi.ajp.2007.06122032

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  65 in total

Review 1.  Non-invasive methods for studying brain energy metabolism: what they show and what it means.

Authors:  G J Kemp
Journal:  Dev Neurosci       Date:  2000 Sep-Dec       Impact factor: 2.984

2.  Increased orbitofrontal cortex levels of choline in depressed adolescents as detected by in vivo proton magnetic resonance spectroscopy.

Authors:  R J Steingard; D A Yurgelun-Todd; J Hennen; J C Moore; C M Moore; K Vakili; A D Young; A Katic; W R Beardslee; P F Renshaw
Journal:  Biol Psychiatry       Date:  2000-12-01       Impact factor: 13.382

3.  Quantitative proton magnetic resonance spectroscopy of the basal ganglia in patients with affective disorders.

Authors:  H Hamakawa; T Kato; J Murashita; N Kato
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1998       Impact factor: 5.270

4.  Brain mechanisms associated with depressive relapse and associated cognitive impairment following acute tryptophan depletion.

Authors:  K A Smith; J S Morris; K J Friston; P J Cowen; R J Dolan
Journal:  Br J Psychiatry       Date:  1999-06       Impact factor: 9.319

5.  Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs.

Authors:  M H Chakos; J A Lieberman; R M Bilder; M Borenstein; G Lerner; B Bogerts; H Wu; B Kinon; M Ashtari
Journal:  Am J Psychiatry       Date:  1994-10       Impact factor: 18.112

6.  Increased N-acetylaspartate in rat striatum following long-term administration of haloperidol.

Authors:  M K Harte; S B Bachus; G P Reynolds
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

7.  Increased medial thalamic choline found in pediatric patients with obsessive-compulsive disorder versus major depression or healthy control subjects: a magnetic resonance spectroscopy study.

Authors:  Ethan A Smith; Aileen Russell; Elisa Lorch; S Preeya Banerjee; Michelle Rose; Jennifer Ivey; Rashmi Bhandari; Gregory J Moore; David R Rosenberg
Journal:  Biol Psychiatry       Date:  2003-12-15       Impact factor: 13.382

Review 8.  Neuroanatomical circuits in depression: implications for treatment mechanisms.

Authors:  W C Drevets; M E Raichle
Journal:  Psychopharmacol Bull       Date:  1992

9.  Anatomical MRI study of basal ganglia in major depressive disorder.

Authors:  Acioly L T Lacerda; Mark A Nicoletti; Paolo Brambilla; Roberto B Sassi; Alan G Mallinger; Ellen Frank; David J Kupfer; Matcheri S Keshavan; Jair C Soares
Journal:  Psychiatry Res       Date:  2003-11-30       Impact factor: 3.222

10.  Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium.

Authors:  Natalya A Uranova; Victor M Vostrikov; Diana D Orlovskaya; Valentina I Rachmanova
Journal:  Schizophr Res       Date:  2004-04-01       Impact factor: 4.939

View more
  27 in total

1.  Sex-specific antidepressant effects of dietary creatine with and without sub-acute fluoxetine in rats.

Authors:  Patricia J Allen; Kristen E D'Anci; Robin B Kanarek; Perry F Renshaw
Journal:  Pharmacol Biochem Behav       Date:  2012-03-10       Impact factor: 3.533

2.  Prevalence of incompletely penetrant Huntington's disease alleles among individuals with major depressive disorder.

Authors:  Roy H Perlis; Jordan W Smoller; Jayalakshmi Mysore; Mei Sun; Tammy Gillis; Shaun Purcell; Marcella Rietschel; Markus M Nöthen; Stephanie Witt; Wolfgang Maier; Dan V Iosifescu; Patrick Sullivan; A John Rush; Maurizio Fava; Hans Breiter; Marcy Macdonald; James Gusella
Journal:  Am J Psychiatry       Date:  2010-04-01       Impact factor: 18.112

3.  Acute restraint-mediated increases in glutamate levels in the rat brain: an in vivo ¹H-MRS study at 4.7 T.

Authors:  Sang-Young Kim; Eun-Ju Jang; Kwan Su Hong; Chulhyun Lee; Do-Wan Lee; Chi-Bong Choi; Hyunseung Lee; Bo-Young Choe
Journal:  Neurochem Res       Date:  2011-12-22       Impact factor: 3.996

4.  The kynurenine pathway in adolescent depression: preliminary findings from a proton MR spectroscopy study.

Authors:  Vilma Gabbay; Leonard Liebes; Yisrael Katz; Songtao Liu; Sandra Mendoza; James S Babb; Rachel G Klein; Oded Gonen
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2009-09-21       Impact factor: 5.067

5.  Brain volume abnormalities in major depressive disorder: a meta-analysis of magnetic resonance imaging studies.

Authors:  P Cédric M P Koolschijn; Neeltje E M van Haren; Gerty J L M Lensvelt-Mulders; Hilleke E Hulshoff Pol; René S Kahn
Journal:  Hum Brain Mapp       Date:  2009-11       Impact factor: 5.038

6.  Childhood adversity is associated with left basal ganglia dysfunction during reward anticipation in adulthood.

Authors:  Daniel G Dillon; Avram J Holmes; Jeffrey L Birk; Nancy Brooks; Karlen Lyons-Ruth; Diego A Pizzagalli
Journal:  Biol Psychiatry       Date:  2009-04-09       Impact factor: 13.382

7.  Striatum-based circuitry of adolescent depression and anhedonia.

Authors:  Vilma Gabbay; Benjamin A Ely; Qingyang Li; Saroja D Bangaru; Aviva M Panzer; Carmen M Alonso; F Xavier Castellanos; Michael P Milham
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2013-05-03       Impact factor: 8.829

8.  Anterior cingulate cortex choline levels in female adolescents with unipolar versus bipolar depression: a potential new tool for diagnosis.

Authors:  Xian-Feng Shi; Lauren N Forrest; M Danielle Kuykendall; Andrew P Prescot; Young-Hoon Sung; Rebekah S Huber; Tracy L Hellem; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  J Affect Disord       Date:  2014-06-02       Impact factor: 4.839

9.  DTI-based connectome analysis of adolescents with major depressive disorder reveals hypoconnectivity of the right caudate.

Authors:  Olga Tymofiyeva; Colm G Connolly; Tiffany C Ho; Matthew D Sacchet; Eva Henje Blom; Kaja Z LeWinn; Duan Xu; Tony T Yang
Journal:  J Affect Disord       Date:  2016-09-19       Impact factor: 4.839

10.  Subcortical biophysical abnormalities in patients with mood disorders.

Authors:  A Kumar; S Yang; O Ajilore; M Wu; R Charlton; M Lamar
Journal:  Mol Psychiatry       Date:  2013-07-23       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.